• Mashup Score: 3

    In his weekly clinical update Dr. Griffin discusses prevalence and clinical outcomes of respiratory syncytial virus versus influenza virus in adults hospitalized with acute respiratory Illness, reconsideration of antinucleocapsid IgG antibody as a marker of SARS-CoV-2 infection postvaccination for mild COVID-19 patients, assessment of COVID-19 as the underlying cause of death among children and…

    Tweet Tweets with this article
    • Dr. Griffin discusses prevalence & clinical outcomes of respiratory syncytial virus versus influenza virus in adults hospitalized w/ acute respiratory Illness, effectiveness of bivalent boosters against severe Omicron infection & more. 📺 https://t.co/J5cKlFShag https://t.co/49iEp4mmWQ

  • Mashup Score: 5

    In his weekly clinical update Dr. Griffin discusses co-detections of other respiratory viruses among children hospitalized with COVID-19, preprint review should form part of PhD programs and postdoc training, early and increased Influenza activity among children, COVID-19 vaccines versus pediatric hospitalization, SARS-CoV-2 variant-related abnormalities detected by prenatal MRI, protective…

    Tweet Tweets with this article
    • TWiV 978 🩺 Dr. Griffin discusses co-detections of other respiratory viruses among children hospitalized w/ COVID-19, preprint review should form part of PhD programs & postdoc training, early & increased Influenza activity among children & more. 📺 https://t.co/SpNMG5wV5W https://t.co/Nx2UwB55fC

  • Mashup Score: 1

    In his weekly clinical update Dr. Griffin discusses China reporting almost 60,000 Covid-related deaths after abrupt shift in policy, detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination, effect of Fluvoxamine vs placebo on time to sustained recovery in outpatients with mild to moderate COVID-19, hyperimmune globulin for…

    Tweet Tweets with this article
    • In his weekly clinical update Dr. Griffin discusses #COVID19 in China, fluvoxamine, long outcomes, hyperimmune globulin for immunocompromised patients and more https://t.co/4MFuYt5WpG https://t.co/bUC528MIpa

  • Mashup Score: 9

    In his weekly clinical update Dr. Griffin discusses the infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave, virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants, antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants, comparative effectiveness of third doses of mRNA-based…

    Tweet Tweets with this article
    • In his weekly clinical update Dr. Griffin discusses the infectiousness of #SARSCoV2, characteristics of the XBB variant, infection and persistence in the human body and brain at autopsy, long-term cardiovascular outcomes of COVID-19 and more https://t.co/zktBaDqbHh https://t.co/NeehR2l5qS